GRIDAI TECHNOLOGIES CORP (GRDX)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$4.67-14.00%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · GRDX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 796.8% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has erratic recent earnings surprises and is a smaller-cap name (higher miss base rate). A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 117 industry peers
GRDX — capital allocation — Unregistered Sales of Equity Securities
Dated 2026-10-28
Unregistered Sales of Equity Securities. The disclosure under
Why it matters: The next earnings date is November 18. Cash needs and operating losses can show whether recent financing covers the business.
Watch forThe report shows cash available and a lower operating loss than Q2's $13.1 million.
Also watch forThe report shows rising operating losses and a new need for financing.
Why it matters: The company said Nasdaq could grant time through October 12 to regain compliance. A later filing or notice would show the outcome.
Worry ifNasdaq issues a delisting notice or denies a plan to regain filing compliance.
Less concerning ifA company filing or Nasdaq notice confirms the 10-K was filed. It also confirms the listing rule issue was fixed.
Why it matters: The company has raised funds as losses grew. The placement terms can show the cash raised and the share dilution involved.
Watch forA filing states how much cash was raised. It shows that the share or warrant sale is limited to the announced amount.
Also watch forA filing shows added share or warrant sales beyond the announced amount, or terms that raise little cash.
Why it matters: Operating losses grew from $3.6 million in Q1 to $13.1 million in Q2. A smaller loss would show progress on cost control.
Supportive ifQ3 operating loss is below $13.1 million.
Worry ifQ3 operating loss is $13.1 million or higher.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$482 on $10,000 · ±4.8% | How much price usually moves either way. |
| Bad day | $1,131 loss on $10,000 · 11.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,176 loss on $10,000 · 61.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Nasdaq cited the late filing as a listing rule breach. A filed 10-K would address the stated compliance issue.
Supportive ifThe company files its 2025 Form 10-K and reports that Nasdaq has restored its filing compliance.
Worry ifThe 10-K remains unfiled, or Nasdaq begins steps to delist the shares.